New chief at Innovative Medicines Canada
April 19, 2017
OTTAWA – Innovative Medicines Canada is pleased to announce the appointment of Pamela Fralick (pictured) as president. Ms. Fralick is an experienced leader who has been fostering positive change in Canada’s health sector for decades. A convener and innovator, Ms. Fralick is one of Canada’s leading, compassionate voices in the health sector.
As the president of Innovative Medicines Canada, Ms. Fralick leads the industry association for Canada’s innovative pharmaceutical companies, working with its members and communities to ensure Canadians have access to the medicines they need, when they need them.
Prior to joining Innovative Medicines Canada, Ms. Fralick was president and CEO of the Canadian Cancer Society, Canada’s largest health charity. Ms. Fralick has also served as president and CEO of the Canadian Healthcare Association (CHA) and the Canadian Physiotherapy Association, and holds an ICD.D designation.
True to her commitment to the health and well-being of Canadians, Ms. Fralick has served on numerous prestigious boards and collaboratives across Canada. She was Chair of the Health Action Lobby, Co-chair of the Canadian Coalition for Public Health in the 21st Century and Chair of the Health Charities Coalition of Canada.
She has been active in many organizations as a senior volunteer, including the Centre for Addiction and Mental Health, the University of Ottawa Institute of Mental Health Research, Triathlon Canada and the International Triathlon Union. She is currently on the boards of Outward Bound Canada (Chair) and the Canada Dance Festival (Past Chair).
About Innovative Medicines Canada
Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.